Clinical Trial Update: Dose Ranging Study of Glycopyrronium Bromide in Patients With Moderate or Severe Chronic Obstructive Pulmonary Disease [Phase 2]

View source ↗

Summary

Phase 2 dose-ranging study of glycopyrronium bromide in moderate-to-severe chronic obstructive pulmonary disease has completed enrollment and results have been …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Glycopyrronium bromide (glycopyrronium bromide)

Snippet

Sponsor: Prosonix Limited | Conditions: Chronic Obstructive Pulmonary Disease | Phase 2 | Status: COMPLETED